学术探索
学术期刊
新闻热点
数据分析
智能评审

CLINICAL-PHARMACOLOGY OF ANTIBIOTICS AND OTHER DRUGS IN CYSTIC-FIBROSIS

被引：59
作者：
PRANDOTA, J
机构：
来源：
DRUGS | 1988年 / 35卷 / 05期
关键词：
D O I：
10.2165/00003495-198835050-00004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：542 / 578
页数：37
相关论文
共 193 条
[61]  
Guggenbichler J P, 1979, Monogr Paediatr, V10, P34
[62]  
GUGLER R, 1981, CLIN PHARMACOL THER, V29, P249
[63]   QUANTITATIVE ASSESSMENT OF EXOCRINE PANCREATIC FUNCTION IN INFANTS AND CHILDREN [J].
HADORN, B ;
ZOPPI, G ;
SHMERLING, DH ;
PRADER, P ;
MCINTYRE, I ;
ANDERSON, CM .
JOURNAL OF PEDIATRICS, 1968, 73 (01) :39-+
[64]   SHOULD CLEARANCE BE NORMALIZED TO BODY-SURFACE OR TO LEAN BODY-MASS [J].
HALLYNCK, TH ;
SOEP, HH ;
THOMIS, JA ;
BOELAERT, J ;
DANEELS, R ;
DETTLI, L .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :523-526
[65]  
HALVORSEN L, 1973, SCAND J GASTROENTERO, V8, P395
[66]  
HARRISON CJ, 1985, PEDIATR PHARMACOL, V5, P7
[67]  
Hendeles L, 1980, APPLIED PHARMACOKINE, P95
[68]  
HENDELES L, 1987, J PEDIATRICS, V111, P303
[69]   THE HIGH LIPID-CONTENT OF RESPIRATORY MUCINS IN CYSTIC-FIBROSIS IS RELATED TO INFECTION [J].
HOUDRET, N ;
PERINI, JM ;
GALABERT, C ;
SCHARFMAN, A ;
HUMBERT, P ;
LAMBLIN, G ;
ROUSSEL, P .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 880 (01) :54-61
[70]   INDIVIDUALIZATION OF TOBRAMYCIN DOSAGE IN PATIENTS WITH CYSTIC-FIBROSIS [J].
HSU, MC ;
AGUILA, HA ;
SCHMIDT, VL ;
MUNZENBERGER, PJ ;
KAUFFMAN, RE ;
POLGAR, G .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1984, 3 (06) :526-529
234567891011